Cargando…
A glycolipid adjuvant, 7DW8-5, provides a protective effect against colonic inflammation in mice by the recruitment of CD1d-restricted natural killer T cells
BACKGROUND/AIMS: The modulation of CD1d-restricted natural killer T (NKT) cells by glycolipids has been considered as a potential therapy against immunologic diseases, including inflammatory bowel disease. A recently identified a glycolipid analog, 7DW8-5, which is derived from α-galactosylceramide...
Autores principales: | Lee, Chansu, Hong, Sung Noh, Kim, Young-Ho |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Association for the Study of Intestinal Diseases
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7609397/ https://www.ncbi.nlm.nih.gov/pubmed/32248672 http://dx.doi.org/10.5217/ir.2019.00132 |
Ejemplares similares
-
Sex-Specific Differences in Cytokine Induction by the Glycolipid Adjuvant 7DW8-5 in Mice
por: Watson, Felicia N., et al.
Publicado: (2022) -
A Glycolipid Adjuvant, 7DW8-5, Enhances CD8+ T Cell Responses Induced by an Adenovirus-Vectored Malaria Vaccine in Non-Human Primates
por: Padte, Neal N., et al.
Publicado: (2013) -
A Glycolipid Adjuvant, 7DW8-5, Enhances the Protective Immune Response to the Current Split Influenza Vaccine in Mice
por: Feng, Huapeng, et al.
Publicado: (2019) -
CD1d-restricted Recognition of Synthetic Glycolipid Antigens by Human Natural Killer T Cells
por: Spada, Franca M., et al.
Publicado: (1998) -
A Glycolipid α-GalCer Derivative, 7DW8-5 as a Novel Mucosal Adjuvant for the Split Inactivated Influenza Vaccine
por: Feng, Huapeng, et al.
Publicado: (2022)